179 related articles for article (PubMed ID: 4599330)
21. Uptake of antilymphocyte globulin by human peripheral lymphocytes.
Brain P; Marston RH
Clin Exp Immunol; 1973 Mar; 13(3):423-6. PubMed ID: 4633851
[TBL] [Abstract][Full Text] [Related]
22. Virus tumorigenesis and immunity: influence of immunostimulation and immunodepression.
Friedman H; Ceglowski WS
Johns Hopkins Med J Suppl; 1974; 3():187-209. PubMed ID: 4609083
[No Abstract] [Full Text] [Related]
23. [Study of the intracytoplasmatic antigens of malignant melanoma cells. Preliminary report].
De Moragas J; Anguera A; Viñas J
Actas Dermosifiliogr; 1971; 62(9):429-32. PubMed ID: 4949557
[No Abstract] [Full Text] [Related]
24. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
Yust I; Wunderlich JR; Mann DL; Buell DN
J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
[No Abstract] [Full Text] [Related]
25. Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma.
Reuben JM; Lee BN; Li C; Gomez-Navarro J; Bozon VA; Parker CA; Hernandez IM; Gutierrez C; Lopez-Berestein G; Camacho LH
Cancer; 2006 Jun; 106(11):2437-44. PubMed ID: 16615096
[TBL] [Abstract][Full Text] [Related]
26. Some recent developments in human tumour immunology.
The TH
Folia Med Neerl; 1972; 15(6):279-90. PubMed ID: 4565658
[No Abstract] [Full Text] [Related]
27. [Evidence for tumor immunity in human malignant melanoma].
Nagel GA
Schweiz Med Wochenschr; 1970 Jun; 100(23):995-1000. PubMed ID: 4947017
[No Abstract] [Full Text] [Related]
28. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells.
Kupsch JM; Tidman NH; Kang NV; Truman H; Hamilton S; Patel N; Newton Bishop JA; Leigh IM; Crowe JS
Clin Cancer Res; 1999 Apr; 5(4):925-31. PubMed ID: 10213230
[TBL] [Abstract][Full Text] [Related]
29. Results of administering B.C.G. to patients with melanoma.
Grant RM; Mackie R; Cochran AJ; Murray EL; Hoyle D; Ross C
Lancet; 1974 Nov; 2(7889):1096-100. PubMed ID: 4139404
[No Abstract] [Full Text] [Related]
30. [Immunological conditions in patients with malignant melanoma of the skin].
Kristensen E
Ugeskr Laeger; 1976 Feb; 138(8):463-8. PubMed ID: 1258214
[No Abstract] [Full Text] [Related]
31. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
Strohal R; Paucz L; Pehamberger H; Stingl G
Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272
[TBL] [Abstract][Full Text] [Related]
32. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
Ferradini L; Mackensen A; Genevée C; Bosq J; Duvillard P; Avril MF; Hercend T
J Clin Invest; 1993 Mar; 91(3):1183-90. PubMed ID: 8450047
[TBL] [Abstract][Full Text] [Related]
33. Cell-mediated immunity against malignant melanoma in monozygous twins.
Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
[No Abstract] [Full Text] [Related]
34. Studies of humoral and cell-mediated immunity in human melanoma.
Mukherji B; Nathanson L; Clark DA
Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
[No Abstract] [Full Text] [Related]
35. The halo naevus and malignant melanoma.
Lancet; 1973 May; 1(7810):982. PubMed ID: 4121601
[No Abstract] [Full Text] [Related]
36. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy of malignant melanoma.
Roenigk HH
Compr Ther; 1975 Aug; 1(4):65-70. PubMed ID: 1220917
[No Abstract] [Full Text] [Related]
38. Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
Kirkwood JM; Mascari RA; Edington HD; Rabkin MS; Day RS; Whiteside TL; Vlock DR; Shipe-Spotloe JM
Cancer; 2000 Jun; 88(12):2693-702. PubMed ID: 10870051
[TBL] [Abstract][Full Text] [Related]
39. Immunology and cutaneous malignant melanoma.
Sober AJ
Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
[No Abstract] [Full Text] [Related]
40. Anti-tumor immunoreactivity in patients with malignant melanoma.
Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
